Literature DB >> 6090542

Transfer and persistence of viral antibody-producing cells in bone marrow transplantation.

B Wahren, G Gahrton, A Linde, P Ljungman, B Lönnqvist, O Ringdén, V A Sundqvist.   

Abstract

Antiviral humoral reactivity was studied after bone marrow transplantation. Antiviral IgG--reflecting the presence of functional B cells--was found for a substantial period after transplantation. However, most patients unexpectedly stopped producing antibody after an extended period of observation (i.e., for more than three months and up to as long as 12 months). This cessation was noted whether the viral reactivity involved was of donor or recipient origin. The transferred viral antibody-producing cells thus usually persisted for only a moderate length of time and seemed to have a finite life span. The findings indicate that donor and recipient memory cells are susceptible to the conditioning regimen or to the treatment that follows transplantation. In a few cases transferred immunity of long duration was seen; this finding indicated the occasional engraftment of memory cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090542     DOI: 10.1093/infdis/150.3.358

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Lisa Swartling; Rickard Nordén; Ebba Samuelsson; Ksenia Boriskina; Davide Valentini; Johan Westin; Heléne Norder; Elda Sparrelid; Per Ljungman
Journal:  Bone Marrow Transplant       Date:  2020-02-18       Impact factor: 5.483

Review 2.  Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?

Authors:  A E Harris; J Styczynski; M Bodge; M Mohty; B N Savani; P Ljungman
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

3.  Designed transfer of specific immune responses with bone marrow transplantation.

Authors:  A Saxon; R Mitsuyasu; R Stevens; R E Champlin; H Kimata; R P Gale
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 4.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

5.  IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.

Authors:  L G Lum; E Burns; M M Janson; P J Martin; B R Giddings; M C Seigneuret; J E Noges; S C Galoforo
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

6.  T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow.

Authors:  G Janossy; H G Prentice; J P Grob; K Ivory; N Tidman; J Grundy; M Favrot; M K Brenner; D Campana; H A Blacklock
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

7.  Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study.

Authors:  A Ambati; L S V Boas; P Ljungman; L Testa; J F de Oliveira; M Aoun; V Colturato; M Maeurer; C M Machado
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

8.  [Guidelines for vaccination of immunocompromised individuals].

Authors:  Ursula Wiedermann; Harald H Sitte; Heinz Burgmann; Alexander Eser; Petra Falb; Heidemarie Holzmann; Maria Kitchen; Marcus Köller; Herwig Kollaritsch; Michael Kundi; Hans Lassmann; Ingomar Mutz; Winfried F Pickl; Elisabeth Riedl; Maria Sibilia; Florian Thalhammer; Barbara Tucek; Werner Zenz; Karl Zwiauer
Journal:  Wien Klin Wochenschr       Date:  2016-07-25       Impact factor: 1.704

9.  Donor and recipient origin of herpesvirus-reactive lymphocytes after bone marrow transplantation. Brief report.

Authors:  P Ljungman; G Gahrton; O Ringdén; B Wahren
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 10.  Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

Authors:  Muhammad A Mir; Minoo Battiwalla
Journal:  Mycopathologia       Date:  2009-01-21       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.